Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
December 05, 2024 | 18:00
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly's biotech collaborators.
Mobile Version